Preclinical assessment of the cardiotoxic potential of anthracycline antibiotics: N-L-leucyl-doxorubicin.
Zbinden
G
G
Institute of Toxicology, Swiss Federal Institute of Technology, Schwerzenbach, Switzerland.
DeCampeenere
D
D
Baurain
R
R
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000633:toxicity; D004562:Electrocardiography / Q000187:drug effects; D004906:Erythrocyte Count / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D007970:Leukopenia / Q000139:chemically induced; D009206:Myocardium / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D051381:Rats
C073409:N-leucyldoxorubicin; D004317:Doxorubicin